Short description
Cellular Dynamics International develops stem cell technologies for drug development and personalized medicine applications.
Description
Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Madison, Wisconsin, United States, North America
Founded on
January 1, 2004
Exited on
July 25, 2013
Went public on
July 25, 2013
Delisted on
May 4, 2015
Stock symbol
ICEL
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$34056 - 789030
Sign in for full access
Investors
No Way, Cannot Access, Absolutely Noaccess, Noaccess, Cannot Access, Noaccess
Sign in for full access
Founders
Craig T. January, Igor Slukvin, James A. Thomson, Thomas M. Palay, Timothy J. Kamp